Skip to main content

Alclometasone topical Pregnancy and Breastfeeding Warnings

Brand names: Aclovate

Medically reviewed by Drugs.com. Last updated on Aug 3, 2023.

Alclometasone topical Pregnancy Warnings

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

Comments: Corticosteroids should not be used extensively in large amounts for prolonged periods of time in pregnant women.

US FDA Pregnancy Category: C

Animal studies have revealed evidence of teratogenicity when corticosteroids are administered systemically or topically. There are no adequate and well-controlled studies in pregnant women.

US FDA Pregnancy Category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Alclometasone topical Breastfeeding Warnings

Use is not recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

See also

References for pregnancy information

  1. (2001) "Product Information. Aclovate (alclometasone topical)." Glaxo Wellcome
  2. TGA. Therapeutic Goods Administration. Australian Drug Evaluation Committee (2007) Prescribing medicines in pregnancy: an Australian categorisation of risk of drug use in pregancy. http://www.tga.gov.au/docs/pdf/medpreg.pdf
  3. Cerner Multum, Inc. "Australian Product Information."

References for breastfeeding information

  1. (2001) "Product Information. Aclovate (alclometasone topical)." Glaxo Wellcome
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
  3. Cerner Multum, Inc. "Australian Product Information."

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer